You are here

  • Home
  • Archive
  • Volume 70, Issue 12
  • Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice

Article info

Article menu
Download PDFPDF
Clinical and epidemiological research
Concise report
Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice

Authors

  1. Correspondence to Ieda Laurindo, Disciplina de Reumatologia, Faculdade de Medicina da Universidade de São Paulo, Av. Dr. Arnaldo, no 455, 3o andar, sala 3190 – Cerqueira César, 05403-010 Sao Paulo, Brazil; monocyte{at}lim17.fm.usp.br
View Full Text

Citation

Ribeiro ACM, Guedes LKN, Moraes JCB, et al
Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice
Annals of the Rheumatic Diseases 2011;70:2144-2147.

Publication history

  • Accepted July 17, 2011
  • First published August 22, 2011.
Online issue publication 
November 02, 2011

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions